One Community, One Question: What Is Your #MYelomaSTORY?
The International Myeloma Foundation Reached Over 41 Million in More Than 45 Countries During 2023 Myeloma Action Month!STUDIO CITY, Calif.,...
Healthcare
Tilray Medical Expands Commercial Footprint in Europe and Broadens Distribution Across the Czech Republic
COLOGNE, Germany, April 06, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company...
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent
SOLANA BEACH, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily...
ABVC BioPharma Provides Vitargus Update on Phase II Site Initiation Visit Conducted at Ramathibodi Hospital in Thailand
Fremont, CA, April 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company...
electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South Africa
ROCKAWAY, N.J., April 06, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness...
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
TUCSON, Ariz., April 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools...
Sernova Responds to Dissident Shareholders’ Misleading Statements and Provides Corporate Updates
The dissident director nominees declined to follow proper protocol to participate in Sernova’s board renewal process and instead are imposing...
Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market
CEO Jim Walesa will lead the combined company, Clearday, as Chief Executive Officer Jagi Gill, Chief Executive Officer and Chairman...
Everest Group recognizes Indegene as a Leader in its Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023
Everest Group Life Sciences Sales and Marketing Operations - Services PEAK Matrix® Assessment 2023 Everest Group recognizes Indegene as a...
RxSight, Inc. to Present at the Needham Healthcare Conference
ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to...
180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement
Priced At-The-Market Under Nasdaq RulesPALO ALTO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180...
HFMA Names Ann Jordan as New CEO
CHICAGO, April 05, 2023 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) announced today that its board of directors...
Reunion Rehabilitation Hospital Peoria Names Shawn McCallum Chief Executive Officer
Shawn McCallum, CEO - Reunion Rehabilitation Hospital Peoria Reunion Rehabilitation Hospital Peoria announced Shawn McCallum as its new CEO. PEORIA,...
Reunion Rehabilitation Hospital Arlington Names Rob Smart Chief Executive Officer
Rob Smart, CEO - Reunion Rehabilitation Hospital Arlington Reunion Rehabilitation Hospital Arlington announced Rob Smart as its new CEO.ARLINGTON, Texas,...
OXOS Medical Raises $23M Series A to Deliver “Radiology Department in a Box” to the Entire Healthcare Value Chain
Co-led by Parkway Venture Capital and Intel Capital, OXOS will leverage funds to expand into clinical, mobile, and home care...
JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors
IRVINE, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement...
Celularity Inc. Announces $6 Million Registered Direct Offering
FLORHAM PARK, N.J., April 05, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic...
MHRA Grants ADvantage Therapeutics Innovative Licensing and Access Pathway (ILAP) Designation for Novel Lead Product AD04™ for Phase 2b Trial in Alzheimer’s Disease
ILAP Designation accelerates patient access and commercializationMIAMI, April 05, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”),...
Surrozen Strengthens Board of Directors with the Appointment of Eric Bjerkholt
SOUTH SAN FRANCISCO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company...
T2 Biosystems Announces Webinar and White Paper Highlighting T2Candida Panel Clinical Data and Best Practices
LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens...